Successfully integrating human papillomavirus testing into your practice.
Integrating human papillomavirus (HPV) testing into the practice of cervical cancer screening is a continuous process that begins and ends with education. An understanding of the basic science and clinical relevance are critical to proper implementation. One must have knowledge of one's own laboratory statistics, clinician awareness, and market forces before the final steps are taken. Additional logistical issues are often laboratory specific or state specific, but are addressed here.
Lozano
Richard
R
Cunningham Pathology, LLC, Birmingham, Ala, USA. thelozanos@mindspring.com
D003581:Cytodiagnosis / Q000379:methods; D005260:Female; D006801:Humans; D025202:Molecular Diagnostic Techniques / Q000379:methods; D027383:Papillomaviridae / Q000302:isolation & purification*; D030361:Papillomavirus Infections / Q000473:pathology* / Q000821:virology*; D014412:Tumor Virus Infections / Q000473:pathology* / Q000821:virology*; D002583:Uterine Cervical Neoplasms / Q000473:pathology* / Q000821:virology*